These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15807862)

  • 1. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
    Cruyssen BV; Peeters H; Hoffman IE; Laukens D; Coucke P; Marichal D; Cuvelier C; Remaut E; Veys EM; Mielants H; De Vos M; De Keyser F
    Clin Exp Immunol; 2005 May; 140(2):354-9. PubMed ID: 15807862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.
    Dassopoulos T; Frangakis C; Cruz-Correa M; Talor MV; Burek CL; Datta L; Nouvet F; Bayless TM; Brant SR
    Inflamm Bowel Dis; 2007 Feb; 13(2):143-51. PubMed ID: 17206688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
    Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
    Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
    Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
    Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFalpha genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type.
    Castro-Santos P; Mozo L; Gutiérrez C; Suárez A
    Clin Immunol; 2006 Dec; 121(3):305-13. PubMed ID: 16952484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM; Flogerzi B; Seibold-Schmid B; Schaffer T; Kun JF; Pittet V; Mueller S; Seibold F
    Am J Gastroenterol; 2009 Oct; 104(10):2508-16. PubMed ID: 19532127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.
    Halfvarson J; Standaert-Vitse A; Järnerot G; Sendid B; Jouault T; Bodin L; Duhamel A; Colombel JF; Tysk C; Poulain D
    Gut; 2005 Sep; 54(9):1237-43. PubMed ID: 15863472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
    Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
    Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].
    Papp M
    Orv Hetil; 2008 Nov; 149(48):2269-76. PubMed ID: 19028649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
    Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
    Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
    Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
    Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
    Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
    Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1.
    Yacyshyn BR; Schievella A; Sewell KL; Tami JA
    Clin Exp Immunol; 2005 Jul; 141(1):141-7. PubMed ID: 15958080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population.
    Marrakchi R; Bougatef K; Moussa A; Ouerhani S; Khodjet-el-Khil H; Messai Y; Mestiri O; Najar T; Benammar-Elgaaeid A
    Inflamm Res; 2009 Apr; 58(4):218-23. PubMed ID: 19184350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn' s disease population.
    Linskens RK; Mallant-Hent RC; Murillo LS; von Blomberg BM; Alizadeh BZ; Peña AS
    Dig Liver Dis; 2004 Jan; 36(1):29-34. PubMed ID: 14971813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease.
    Van Kemseke C; Belaïche J; Steeman C; Louis E
    Acta Gastroenterol Belg; 2003; 66(1):1-6. PubMed ID: 12812142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease.
    Smith BR; Arnott ID; Drummond HE; Nimmo ER; Satsangi J
    Inflamm Bowel Dis; 2004 Sep; 10(5):521-8. PubMed ID: 15472511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease.
    Odes S; Friger M; Vardi H; Claessens G; Bossuyt X; Riis L; Munkholm P; Wolters F; Yona H; Hoie O; Beltrami M; Tsianos E; Katsanos K; Mouzas I; Clofent J; Monteiro E; Messori A; Politi P; O'Morain C; Limonard C; Russel M; Vatn M; Moum B; Stockbrugger R; Vermeire S;
    Inflamm Bowel Dis; 2007 Jul; 13(7):874-81. PubMed ID: 17278126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.